K S Gregg1, B Barin, D Pitrak, C Ramaprasad, K Pursell. 1. Department of Internal Medicine, Division of Infectious Diseases, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Abstract
INTRODUCTION: As more solid organ transplantations are performed in patients infected with human immunodeficiency virus (HIV), post-transplant complications in this population are becoming better defined. METHODS: Using serum samples from the Solid Organ Transplantation in HIV: Multi-Site Study, we studied the epidemiology of acquired hypogammaglobulinemia (HGG) after liver transplantation (LT) in 79 HIV-infected individuals with a median CD4 count at enrollment of 288 (interquartile range 200-423) cells/μL. Quantitative immunoglobulin G (IgG) levels before and after LT were measured, with moderate and severe HGG defined as IgG 350-500 mg/dL and <350 mg/dL, respectively. Incidence, risk factors, and associated outcomes of moderate or worse HGG were evaluated using Kaplan-Meier estimator and proportional hazards (PH) models. RESULTS: The 1-year cumulative incidence of moderate or worse HGG was 12% (95% confidence interval [CI]: 6-22%); no new cases were observed between years 1 and 2. In a multivariate PH model, higher pre-transplant model for end-stage liver disease score (P = 0.04) and treated acute rejection (P = 0.04) were both identified as significant predictors of moderate or worse HGG. There was a strong association of IgG levels <500 mg/dL with non-opportunistic serious infection (hazard ratio [95% CI]: 3.5 [1.1-10.6]; P = 0.03) and mortality (3.2 [1.1-9.4]; P = 0.04). These associations held after adjustment for important determinants of infection and survival among the entire cohort. CONCLUSION: These results suggest that a proportion of HIV-positive LT recipients will develop clinically significant HGG after transplantation.
INTRODUCTION: As more solid organ transplantations are performed in patients infected with human immunodeficiency virus (HIV), post-transplant complications in this population are becoming better defined. METHODS: Using serum samples from the Solid Organ Transplantation in HIV: Multi-Site Study, we studied the epidemiology of acquired hypogammaglobulinemia (HGG) after liver transplantation (LT) in 79 HIV-infected individuals with a median CD4 count at enrollment of 288 (interquartile range 200-423) cells/μL. Quantitative immunoglobulin G (IgG) levels before and after LT were measured, with moderate and severe HGG defined as IgG 350-500 mg/dL and <350 mg/dL, respectively. Incidence, risk factors, and associated outcomes of moderate or worse HGG were evaluated using Kaplan-Meier estimator and proportional hazards (PH) models. RESULTS: The 1-year cumulative incidence of moderate or worse HGG was 12% (95% confidence interval [CI]: 6-22%); no new cases were observed between years 1 and 2. In a multivariate PH model, higher pre-transplant model for end-stage liver disease score (P = 0.04) and treated acute rejection (P = 0.04) were both identified as significant predictors of moderate or worse HGG. There was a strong association of IgG levels <500 mg/dL with non-opportunistic serious infection (hazard ratio [95% CI]: 3.5 [1.1-10.6]; P = 0.03) and mortality (3.2 [1.1-9.4]; P = 0.04). These associations held after adjustment for important determinants of infection and survival among the entire cohort. CONCLUSION: These results suggest that a proportion of HIV-positive LT recipients will develop clinically significant HGG after transplantation.
Authors: Natalie H Yip; David J Lederer; Steven M Kawut; Jessie S Wilt; Frank D'Ovidio; Yuanjia Wang; Edward Dwyer; Joshua R Sonett; Selim M Arcasoy Journal: Am J Respir Crit Care Med Date: 2006-01-06 Impact factor: 21.405
Authors: M Fernández-Ruiz; F López-Medrano; P Varela-Peña; D Lora-Pablos; A García-Reyne; E González; J M Morales; R San Juan; C Lumbreras; E Paz-Artal; A Andrés; J M Aguado Journal: Am J Transplant Date: 2012-07-23 Impact factor: 8.086
Authors: M H Yamani; R K Avery; S D Mawhorter; J B Young; N B Ratliff; R E Hobbs; P M McCarthy; N G Smedira; M Goormastic; D Pelegrin; R C Starling Journal: J Heart Lung Transplant Date: 2001-04 Impact factor: 10.247
Authors: N S Goldfarb; R K Avery; M Goormastic; A C Mehta; R Schilz; N Smedira; L Pien; M T Haug; S M Gordon; L K Hague; J M Dresing; T Evans-Walker; J R Maurer Journal: Transplantation Date: 2001-01-27 Impact factor: 4.939
Authors: M E Roland; B Barin; L Carlson; L A Frassetto; N A Terrault; R Hirose; C E Freise; L Z Benet; N L Ascher; J P Roberts; B Murphy; M J Keller; K M Olthoff; E A Blumberg; K L Brayman; S T Bartlett; C E Davis; J M McCune; B M Bredt; D M Stablein; P G Stock Journal: Am J Transplant Date: 2007-12-18 Impact factor: 8.086